American Society of Clinical Oncology

Oncology & Cancer

Androgen receptor abnormality may not be associated

Findings from a small prospective study suggest that androgen receptor V7 (or AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate cancer (mCRPC). ...

Oncology & Cancer

Game-changing shift occurring in cancer discovery and treatment

Research advances that have come to fruition over the past year demonstrate extraordinary progress in the fight against cancer, according to a new report released today by the American Society of Clinical Oncology (ASCO). ...

page 2 from 7